Percutaneous closure of ductus arteriosus with the amplatzer prosthesis. The Brazilian experience

OBJECTIVE - To report the results of percutaneous occlusion of persistent ductus arteriosus with the Amplatzer prosthesis in 2 Brazilian cardiological centers. METHODS - From May 1998 to July 2000, 33 patients with clinical and laboratory diagnosis of persistent ductus arteriosus underwent attempts at percutaneous implantation of the Amplatzer prosthesis. The median age was 36 months (from 6 months to 38 years), and the median weight was 14kg (from 6 to 92kg). Sixteen patients (48.5%) were under 2 years of age at the time of the procedure. All patients were followed up with periodical clinical and echocardiographic evaluations to assess the presence and degree of residual shunt and possible complications, such as pseudocoarctation of the aorta and left pulmonary artery stenosis. RESULTS - The minimum diameter of the arterial ducts ranged from 2.5 to 7.0mm (mean of 4.0±1.0, median of 3.9). The rate of success for implantation of the prosthesis was 100%. Femoral pulse was lost in 1 patient. The echocardiogram revealed total closure prior to hospital discharge in 30 patients, and in the follow-up visit 3 months later in the 3 remaining patients. The mean follow-up duration was 6.4±3.4 months. All patients were clinically well, asymptomatic, and did not need medication. No patient had narrowing of the left pulmonary artery or of the aorta. No early or late embolic events occurred, nor did infectious endarteritis. A new hospital admission was not required for any patient. CONCLUSION - The Amplatzer prosthesis for persistent ductus arteriosus is safe and highly effective for occlusion of ductus arteriosus of varied diameters, including large ones in small symptomatic infants

Eficácia do mentol como anestésico para juvenis de tilápia-do-nilo (Oreochromis niloticus) Menthol efficiency as anesthetic for juveniles Nile tilapia Oreochromis niloticus

Em três experimentos, testou-se a eficiência do mentol como anestésico para a tilápia-do-nilo (Oreochromis niloticus), por meio da avaliação de eventos comportamentais, da verificação da margem de segurança do anestésico e das respostas de estresse. No primeiro experimento, foram testadas seis diferentes concentrações de mentol para avaliar o tempo de indução à anestesia. No segundo, foram realizados dois testes com o objetivo de verificar a margem de segurança do anestésico. No terceiro, avaliou-se o efeito estressante do anestésico. A concentração 250mg L-1 de mentol foi a mais adequada para indução de anestesia cirúrgica. Para anestesia voltada para biometria e breve inspeção visual do animal, a concentração mais adequada foi 150-200mg L-1. O dobro da concentração ideal (500mg L-1) não acarretou a morte nos indivíduos, indicando boa margem de segurança para o uso desse anestésico. O mentol, mesmo em sua concentração adequada, induziu ao aumento na glicose sanguínea, caracterizando estresse no peixe. Conclui-se que o mentol não é um anestésico eficaz para juvenis de tilápia durante procedimentos de rotina na piscicultura.<br>This work tested the effectiveness of menthol as anesthetic for Nile tilápia (Oreochromis niloticus) by the evaluation of behavioral events, the safety margin of the anesthetic, and stress response. On first experiment, six different anesthetic concentrations were tested to evaluate the induction time to anesthesia. On second experiment, two tests were carried out to verify the safety margin of the anesthetic. On third experiment, stress responses were evaluated. The safe concentration to induce a surgical anesthesia was 250mg L-1. To a brief handling and visual inspection, the appropriated concentration was 150-200mg L-1. There was no mortality after exposure to 500mg L-1, indicating a good safety margin for this anesthetic. Menthol even in its adequate dosage induced a rise in glucose concentrations indicating a stress response of the fish. Thus menthol is an ineffective anesthetic to juveniles tilapia during routine procedures in fish culture